Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes
Clinical trial NCT03215069 · COMPLETED
Trial details
- NCT number
- NCT03215069
- Sponsor
- Mount Sinai Hospital, Canada
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2024-12-31
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.